|
GXYLT2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.819160E-04 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.175960E-03 |
| Normal-vs-Stage2 |
9.598000E-02 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.820240E-01 |
| Stage1-vs-Stage2 |
5.073800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.781800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.165000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.351300E-04 |
| Normal-vs-AfricanAmerican |
2.428500E-02 |
| Normal-vs-Asian |
2.784000E-01 |
| Caucasian-vs-AfricanAmerican |
5.221400E-01 |
| Caucasian-vs-Asian |
3.563200E-01 |
| AfricanAmerican-vs-Asian |
4.184000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.858000E-03 |
| Normal-vs-Female |
1.175930E-02 |
| Male-vs-Female |
9.603200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.196400E-02 |
| Normal-vs-Extreme_Weight |
4.200000E-02 |
| Normal-vs-Obese |
4.124400E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.275600E-01 |
| Normal_Weight-vs-Obese |
3.455800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
5.947200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.105800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.555630E-02 |
| Normal-vs-Age(61-80Yrs) |
1.085720E-02 |
| Normal-vs-Age(81-100Yrs) |
N/A |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.729620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.128800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.753800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
N/A |
| Normal-vs-Grade 3 |
N/A |
| Normal-vs-Grade 4 |
N/A |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
6.296200E-01 |
| Grade 2-vs-Grade 4 |
N/A |
| Grade 3-vs-Grade 4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.083960E-03 |
| Normal-vs-N1 |
2.044800E-01 |
| N0-vs-N1 |
4.898800E-01 |
|
|
